Post Profile

Related Posts

Talactoferrin Phase II Trial In Non-Small Cell Lung Cancer Shows Promise

Health : Medical News Today

Data from a Phase II randomized, double-blind, placebo-controlled clinical trial which assessed talactoferrin (an oral immunotherapy) in individuals who had previously received treatment for non-small cell lung cancer (NSCLC) has be...

Promising Trial Results of Brigatinib Show That All Next-Gen ALK Inhibitors May Not Be Created Equal

Health : Newswise Medical News

Phase I/II clinical trial results reported at the American Society for Clinical Oncology (ASCO) Annual Meeting 2015 show promising results for investigational drug brigatinib against ALK+ non-small cell lung cancer (NSCLC), with 58 ...

Yale Researchers Present Results Of Phase II Phenoxodiol Clinical Trial In Prostate Cancer Patients At ASCO 2009 Genitourinary Cancers Symposium

Health : Medical News Today

Marshall Edwards, Inc. (NASDAQ: MSHL) -- Preliminary results from a Phase II clinical trial of oral phenoxodiol in patients with prostate cancer to be presented by Yale researchers at the ASCO Genitourinary Cancers Symposium in Orla...

NovaRx Initiates Pivotal Phase III Clinical Trial In Lung Cancer Patients

Health : Medical News Today

NovaRx Corporation announced that the company initiated its pivotal Phase III clinical trial of Lucanix(R) (belagenpumatucel-L) in the treatment of advanced non-small cell lung cancer (NSCLC). The first patient enrolled in the study...

Endocyte Announces Positive Interim Results From Phase II Clinical Trial Of EC145 In Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Health : Medical News Today

Endocyte Inc. has announced positive interim results from an ongoing Phase II clinical study of EC145 in patients with advanced non-small cell lung cancer (NSCLC). The single arm Phase II study is designed to evaluate treatment with...


Copyright © 2016 Regator, LLC